Targeting ADAR1-mediated RNA editing inhibits hepatic stellate cell activation and liver fibrosis by enhancing HSC-intrinsic innate immunity. [PDF]
Xi Y +11 more
europepmc +1 more source
Adenosine deaminase acting on RNA1 mutation in chilblain lupus treated with tofacitinib. [PDF]
Velaoras AT +6 more
europepmc +1 more source
8-Chloro-adenosine inhibits breast cancer progression by inducing ferroptosis via the ADAR1/miR-101-3p/SLC7A11 axis. [PDF]
Hao M +8 more
europepmc +1 more source
Two codes of RNA editing by deamination in human diseases. [PDF]
Min DJ, Lee S, Lee YS, Cho J.
europepmc +1 more source
RNA editing in cardiovascular health and disease. [PDF]
Huang X, Solomon C, McVey DG, Ye S.
europepmc +1 more source
SARS-CoV-2-induced dysregulation in ADAR editing patterns persists post viral clearance in individuals with mild COVID-19. [PDF]
Mukundan Nair A, Piontkivska H.
europepmc +1 more source
Characterization of Mitochondrial Double-Stranded RNA Levels in Non-Small Cell Lung Carcinoma. [PDF]
Krieger MR +12 more
europepmc +1 more source
Microglia replacement by ER-Hoxb8 conditionally immortalized macrophages provides insight into Aicardi-Goutières syndrome neuropathology. [PDF]
Nemec KM +21 more
europepmc +1 more source
ADAR1-Mediated RNA Editing Regulates Innate Immunity in Pulmonary Hypertension. [PDF]
Shen Y, Bisserier M.
europepmc +1 more source

